Characteristics of pheochromocytoma in a 4-to 20-year-old population

被引:90
作者
Barontini, Marta [1 ]
Levin, Gloria [1 ]
Sanso, Gabriela [1 ]
机构
[1] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol, CONICET, RA-1425 Buenos Aires, DF, Argentina
来源
PHEOCHROMOCYTOMA | 2006年 / 1073卷
关键词
children; pheochromocytoma; VHL; MEN; 2; hypertension; catecholamines;
D O I
10.1196/annals.1353.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypertension in children and adolescents has become a major health problem recently recognized, and in a significant number of patients it is due to an endocrine tumor. The aim of this study was to establish the characteristics of pheochromocytoma in a population of 58 patients between 4 and 20 years of age studied at our Center. They represented a 23% of the total population of 255 pheochromocytoma patients studied. In the younger group (under 20 years of age), there was a marked predominance of severe sustained hypertension (93%), only 7% presented paroxysmal hypertension and none of them was normotensive. The youngsters studied showed a higher incidence of bilateral adrenal pheochromocytoma (34%) and extra-adrenal pheochromocytoma (22%). Malignancy was found in 12% of these patients. In addition, the incidence of familial pheochromocytorna was elevated in these patients (39%). Surprisingly, in contrast with the adult population where the most frequent familial pheochromocytomas were multiple endocrine neoplasia (MEN) type 2A (15%), the younger population showed a higher predominance of von Hippel-Lindau (VHL) (28%) and lower incidence of MEN 2A, MEN 213, neurofibromatosis (NF), and succinate dehydrogenase subunit B (SDHB). In the VHL group, only two patients belonging to one family, showed the R167W mutation, while the others showed novel mutations in conserved amino acids. It may be speculated that the high incidence of VHL in youngsters may account for the biochemical and clinical features they usually present.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 26 条
  • [1] BARONTINI M, 2004, REV HOSP NINOS BAIRE, V46, P45
  • [2] Pheochromocytoma: State-of-the-art and future prospects
    Bravo, EL
    Tagle, R
    [J]. ENDOCRINE REVIEWS, 2003, 24 (04) : 539 - 553
  • [3] Bravo Emmanuel L., 2004, Arq Bras Endocrinol Metab, V48, P746, DOI 10.1590/S0004-27302004000500021
  • [4] Pheochromocytoma in children
    Ciftci, AO
    Tanyel, FC
    Senocak, ME
    Büyükpamukçu, N
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2001, 36 (03) : 447 - 452
  • [5] EINSENHOFER G, 1986, CLIN CHEM, V32, P2030
  • [6] Fonkalsrud E W, 1991, Prog Pediatr Surg, V26, P103
  • [7] Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx
    Gimm, O
    [J]. FAMILIAL CANCER, 2005, 4 (01) : 17 - 23
  • [8] Clinical experience over 48 years with pheochromocytoma
    Goldstein, RE
    O'Neill, JA
    Holcomb, GW
    Morgan, WM
    Neblett, WW
    Oates, JA
    Brown, N
    Nadeau, J
    Smith, B
    Page, DL
    Abumrad, NN
    Scott, HW
    [J]. ANNALS OF SURGERY, 1999, 229 (06) : 755 - 764
  • [9] PHEOCHROMOCYTOMA IN THE PEDIATRIC AGE GROUP - CURRENT STATUS
    KAUFMAN, BH
    TELANDER, RL
    VANHEERDEN, JA
    ZIMMERMAN, D
    SHEPS, SG
    DAWSON, B
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1983, 18 (06) : 879 - 884
  • [10] Koch C A, 2001, Endocr Regul, V35, P43